This Solicitation opportunity from Department Of Defense was posted on June 3, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
AMPHOTERICIN B LIPO
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The contract involves the procurement of Amphotericin B Liposomal formulation, identified by the National Stock Number 6505-01-539-6542. The purchase request number for this acquisition is 7017025659, with a quantity of one unit specified. The solicitation, numbered SPE2DP-26-T-3683, was posted on June 3, 2026, with responses due by June 9, 2026. This indicates a short timeframe for submissions, emphasizing urgency or prioritization. The contract is issued by the Defense Logistics Agency under the Department of Defense, reflecting a federal procurement. The solicitation is categorized as a general solicitation without specified set-aside type or industry classification (NAICS code). The place of performance and detailed office address remain unspecified, suggesting potential flexibility in delivery or remote coordination. The official solicitation and related documents can be accessed through the Defense Logistics Agency’s acquisition portal.
General Info
Agency
NAICS
Place of Performance
USSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Submission Closed
